Emergent BioSolutions, Inc. (EBS)
6.33
-0.04
(-0.63%)
USD |
NYSE |
Oct 02, 16:00
6.335
0.00 (0.00%)
After-Hours: 20:00
Emergent BioSolutions Market Cap : 324.73M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 324.73M |
| October 01, 2026 | 326.78M |
| September 30, 2026 | 338.58M |
| September 29, 2026 | 355.00M |
| September 28, 2026 | 351.92M |
| September 25, 2026 | 348.33M |
| September 24, 2026 | 347.30M |
| September 23, 2026 | 342.17M |
| September 22, 2026 | 346.79M |
| September 21, 2026 | 336.02M |
| September 18, 2026 | 348.84M |
| September 17, 2026 | 360.13M |
| September 16, 2026 | 346.28M |
| September 15, 2026 | 326.27M |
| September 14, 2026 | 327.29M |
| September 11, 2026 | 319.60M |
| September 10, 2026 | 301.13M |
| September 09, 2026 | 291.38M |
| September 08, 2026 | 307.80M |
| September 04, 2026 | 318.57M |
| September 03, 2026 | 319.60M |
| September 02, 2026 | 331.40M |
| September 01, 2026 | 319.09M |
| August 31, 2026 | 312.93M |
| August 28, 2026 | 303.18M |
| Date | Value |
|---|---|
| August 27, 2026 | 304.72M |
| August 26, 2026 | 306.26M |
| August 25, 2026 | 289.33M |
| August 24, 2026 | 265.73M |
| August 21, 2026 | 260.60M |
| August 20, 2026 | 247.27M |
| August 19, 2026 | 250.86M |
| August 18, 2026 | 239.06M |
| August 17, 2026 | 230.85M |
| August 14, 2026 | 235.47M |
| August 13, 2026 | 230.34M |
| August 12, 2026 | 233.42M |
| August 11, 2026 | 228.28M |
| August 10, 2026 | 229.31M |
| August 07, 2026 | 248.29M |
| August 06, 2026 | 272.40M |
| August 05, 2026 | 386.80M |
| August 04, 2026 | 388.34M |
| August 03, 2026 | 379.39M |
| July 31, 2026 | 374.00M |
| July 30, 2026 | 376.07M |
| July 29, 2026 | 380.73M |
| July 28, 2026 | 378.66M |
| July 27, 2026 | 379.69M |
| July 24, 2026 | 376.07M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Exelixis, Inc. | 14.53B |
| Capricor Therapeutics, Inc. | 520.08M |
| ADMA Biologics, Inc. | 2.190B |
| Akebia Therapeutics, Inc. | 235.06M |
| Arcutis Biotherapeutics, Inc. | 3.160B |
Market Cap Related Metrics
| PS Ratio | 0.4459 |
| Price to Book Value | 0.9512 |
| Price to Free Cash Flow | 3.998 |
| Price | 6.33 |
| Earnings Yield | -56.14% |
| Operating PE Ratio | 2.508 |